These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 12562878)

  • 1. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases.
    Van Dyke TE; Serhan CN
    J Dent Res; 2003 Feb; 82(2):82-90. PubMed ID: 12562878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
    Fierro IM; Serhan CN
    Braz J Med Biol Res; 2001 May; 34(5):555-66. PubMed ID: 11323741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoxins in chronic inflammation.
    Kantarci A; Van Dyke TE
    Crit Rev Oral Biol Med; 2003; 14(1):4-12. PubMed ID: 12764016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural resolution of inflammation.
    Freire MO; Van Dyke TE
    Periodontol 2000; 2013 Oct; 63(1):149-64. PubMed ID: 23931059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of inflammation in periodontitis.
    Kantarci A; Van Dyke TE
    J Periodontol; 2005 Nov; 76(11 Suppl):2168-74. PubMed ID: 16277590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.
    Serhan CN
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():433-55. PubMed ID: 12432935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators.
    Serhan CN; Jain A; Marleau S; Clish C; Kantarci A; Behbehani B; Colgan SP; Stahl GL; Merched A; Petasis NA; Chan L; Van Dyke TE
    J Immunol; 2003 Dec; 171(12):6856-65. PubMed ID: 14662892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis.
    Kantarci A; Oyaizu K; Van Dyke TE
    J Periodontol; 2003 Jan; 74(1):66-75. PubMed ID: 12593599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proresolution mediators and receptors: novel drug targets for enhancing pharmacological armamentarium against periodontal inflammation.
    Grover V; Malhotra R; Kapoor A; Singh J; Sachdeva S
    Infect Disord Drug Targets; 2013 Feb; 13(1):75-84. PubMed ID: 23713671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids.
    Spokas EG; Rokach J; Wong PY
    Methods Mol Biol; 1999; 120():213-47. PubMed ID: 10343320
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoxin signaling in neutrophils and their role in periodontal disease.
    Kantarci A; Van Dyke TE
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):289-99. PubMed ID: 15979867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
    Yacoubian S; Serhan CN
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradigm shift in the pharmacological management of periodontal diseases.
    Hasturk H; Kantarci A; Van Dyke TE
    Front Oral Biol; 2012; 15():160-76. PubMed ID: 22142963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity.
    Serhan CN; Levy BD; Clish CB; Gronert K; Chiang N
    Ernst Schering Res Found Workshop; 2000; (31):143-85. PubMed ID: 10943332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins.
    Romano M
    Inflamm Allergy Drug Targets; 2006 Apr; 5(2):81-90. PubMed ID: 16613567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epi-lipoxins.
    Gilroy DW
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():49-54. PubMed ID: 15962098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-resolving mediators in the regulation of periodontal disease.
    Van Dyke TE
    Mol Aspects Med; 2017 Dec; 58():21-36. PubMed ID: 28483532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators.
    Wada K; Qiu FH; Stahl GL; Serhan CN
    J Hematother Stem Cell Res; 2001 Feb; 10(1):75-9. PubMed ID: 11276361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG; Khreiss T; József L
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.